Chart Industries, Inc. Weak Guidance Highlights Q4 Results
Chart Industries’ (NASDAQ:GTLS) overall fourth quarter 2013 EPS and awards were mostly in line with expectations; however, we believe this will be overshadowed by lower-than-expected 2014 EPS guidance ($3.10-$3.50 versus consensus $3.67) and more subdued market commentary regarding near-term growth prospects. There was already a somewhat downward bias to 2014 consensus EPS, the more cautious market commentary about near-term growth prospects may come as a … Continue reading Chart Industries, Inc. Weak Guidance Highlights Q4 Results
Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page
Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker of cardiovascular devices, said Monday it expects to submit a … Continue reading Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page
Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High
InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were demonstrated on both of the key secondary endpoints of six-minute … Continue reading Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High
Zulily (NASDAQ:ZU) Posts Stunningly Good Fourth Quarter
Zulily (NASDAQ:ZU) needed to deliver upside to consensus projections in the fourth quarter, and the magnitude of the top- and bottom-line beat was more than adequate.. The doubling of the active customer base year-to-year is encouraging, and the leverage on marketing spending highlights that there is still significant untapped demand. Flow-through to profitability on higher revenues was exceptional; adjusted EBITDA were double consensus estimates. The … Continue reading Zulily (NASDAQ:ZU) Posts Stunningly Good Fourth Quarter
Restaurant Stocks in the News – BAGL, BBRG
Bravo Brio Restaurant (NASDAQ:BBRG) delivered 4Q13 operating earnings of $0.30 per share. Results were driven by same-store sales of (1.3%) at Bravo and (1.5%) at Brio. Total revenues decreased approximately (5.2%) y/y to $106.1 million, based partially on same-store sales of (1.3%) at Bravo and (1.5%) at Brio. The company opened 4 new Brio during the quarter. Brio and Bravo same-store sales reflect approximately 3.0% … Continue reading Restaurant Stocks in the News – BAGL, BBRG
Morning Watchlist: Apollo Investment, XOMA, Taminco, Hyperion Pharma
Shares in Apollo Investment Corporation (NASDAQ:AINV) dropped more than 5% pre-market after the company said it has priced a public offering of 12.0 million shares. Underwriters have the option to buy an additional 1.8 million shares. The company didn’t give the price of the offer. XOMA Corp (NASDAQ:XOMA) is moving nearly 5% higher after the drug maker announced that gevokizumab, the company’s IL-1 beta modulating … Continue reading Morning Watchlist: Apollo Investment, XOMA, Taminco, Hyperion Pharma
